CLRB

Cellectar Biosciences Stock Price

0.9999
0.0098 (0.99%)
Upgrade to Real-Time
Afterhours (Closed)
0.9999

Low
0.81

52 Week Range

High
2.98

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Cellectar Biosciences Inc CLRB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0098 0.99% 0.9999 00:00:02
Open Price Low Price High Price Close Price Prev Close
0.975 0.9715 1.02 1.01 0.9901
Bid Price Ask Price Spread News
0.9911 1.34 0.3489 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
721 301,864 $ 0.9834001 $ 296,853 - 0.81 - 2.98
Last Trade Time Type Quantity Stock Price Currency
19:44:44 5 $ 1.00 USD

Period:

Draw Mode:

Cellectar Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 61.10M 61.10M 60.82M $ - $ - -0.90 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 429.00k 1.10%

more financials information »

Cellectar Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLRB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.021.050.9651.02400,558-0.0201-1.97%
1 Month0.841.090.810.9759588620,8530.159919.04%
3 Months1.201.320.811.04957,265-0.2001-16.68%
6 Months1.912.090.811.27792,737-0.9101-47.65%
1 Year1.182.980.811.811,249,586-0.1801-15.26%
3 Years2.634.280.811.84641,829-1.63-61.98%
5 Years28.4031.890.815.34527,384-27.40-96.48%

Cellectar Biosciences Description

Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.


Your Recent History
NASDAQ
CLRB
Cellectar ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.